The better burn

Gastrointestinal Endoscopy

Volumn 61, Issue 2, 2005, Pages 241-242

  Sampliner, Richard E ^a  

^a UNIVERSITY OF ARIZONA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PANTOPRAZOLE;

ARGON PLASMA COAGULATION; BARRETT ESOPHAGUS; CANCER GRADING; CARDIA; CATHETER ABLATION; DATA ANALYSIS; DIAGNOSTIC ACCURACY; EARLY CANCER; EDITORIAL; ENDOSCOPIC THERAPY; ESOPHAGUS BIOPSY; ESOPHAGUS MUCOSA; ESOPHAGUS MUSCLE; HIGH RISK PATIENT; HUMAN; INTESTINE METAPLASIA; LOWER ESOPHAGUS SPHINCTER; LYMPH NODE METASTASIS; MUSCLE LENGTH; PRIORITY JOURNAL; RANDOMIZATION; VALIDATION PROCESS;

BARRETT ESOPHAGUS; ELECTROCOAGULATION; HUMANS; LASER COAGULATION;

EID: 13844318793     PISSN: 00165107     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0016-5107(04)02798-1     Document Type: Editorial

References (13)

1. G.S. Dulai, D.M. Jensen, G. Cortina, L. Fontana, and A. Ippoliti Randomized trial of argon plasma coagulation versus multipolar electrocoagulation for ablation of Barrett's esophagus Gastrointest Endosc 61 2005 232 240
2. M. Hage, P.D. Siersema, H. van Dekken, E.W. Steyerberg, J. Haringsma, and W. van de Vrie 5-aminolevulinic acid photodynamic therapy versus argon plasma coagulation for ablation of Barrett's oesophagus: a randomised trial Gut 53 2004 785 790
3. T. Lembo, A.F. Ippoliti, C. Ramers, and W.M. Weinstein Inflammation of the gastro-oesophageal junction (carditis) in patients with symptomatic gastro-oesophageal reflux disease: a prospective study Gut 45 1999 484 488
4. R. Fass, R.E. Sampliner, I.B. Malagon, C.W. Hayden, L. Camargo, and C.S. Wendel Failure of oesophageal acid control in candidates for Barrett's oesophagus reversal on a very high dose of proton pump inhibitor Aliment Pharmacol Ther 14 2000 597 602
5. P. Sharma, A. Bhattacharyya, H.S. Garewal, and R.E. Sampliner Durability of new squamous epithelium following endoscopic reversal of Barrett's esophagus Gastrointest Endosc 50 1999 159 164
6. B. Overholt, C. Lightdale, K. Wang, M. Canto, S. Burdick, and H. Barr International, multicenter, partially blinded, randomised study of the efficacy of photodynamic therapy (PDT) using porfimer sodium (POR) for the ablation of high-grade dysplasia (HGD) in Barrett's esophagus (BE): results of 24-month follow-up [abstract] Gastroenterology 124 2003 A20
7. B. Reid, D. Levine, G. Longton, P. Blount, and P. Rabinovitch Predictors of progression to cancer in Barrett's esophagus: baseline histology and flow cytometry identify low and high risk patient subsets Am J Gastroenterol 95 2000 1669 1676
8. B. Reid, L. Prevo, P. Galipeau, C.A. Sanchez, G. Longton, and D. Levine Predictors of progression in Barrett's esophagus II: baseline 17p (p53) loss of heterozygosity identifies a patient subset at increased risk for neoplastic progression Am J Gastroenterol 96 2001 2839 2848
9. B.F. Overholt, M. Panjehpour, and J.M. Haydek Photodynamic therapy for Barrett's esophagus: follow-up in 100 patients Gastrointest Endosc 49 1999 1 7
10. A. May, L. Gossner, O. Pech, A. Fritz, E. Gunter, and G. Mayer Local endoscopic therapy for intraepithelial high-grade neoplasia and early adenocarcinoma in Barrett's oesophagus: acute-phase and intermediate results of a new treatment approach Eur J Gastroenterol Hepatol 14 2002 1085 1091
11. M. Kinjo, A. Maringhini, K.K. Wang, and E.P. DiMagno Is endoscopic ultrasonography (EUS) cost effective to screen for cancer in patients with Barrett's esophagus [abstract]? Gastrointest Endosc 40 1994 205A
12. I.A. Scotiniotis, M.L. Kochman, J.D. Lewis, E.E. Furth, E.F. Rosato, and G.C. Ginsberg Accuracy of EUS in the evaluation of Barrett's esophagus and high-grade dysplasia or intra-mucosal carcinoma Gastrointest Endosc 54 2001 689 696
13. N.S. Buttar, K.K. Wang, L.S. Lutzke, K.K. Krishnadath, and M.A. Anderson Combined endoscopic mucosal resection and photodynamic therapy for esophageal neoplasia with Barrett's esophagus Gastrointest Endosc 54 2001 682 688